Lack of Survival Advantage in Patients with Advanced Squamous Cell Carcinomas of the Oral Cavity Receiving Neoadjuvant Chemotherapy Prior to Local Therapy, Despite Achieving an Initial High Clinical Complete Remission Rate
Neoadjuvant Chemotherapy with Cisplatin and 5-Fluorouracil, Both in Continuous 96-Hour Infusion, in the Treatment of Locally Advanced Head and Neck Cancer
A Phase II Trial of Vinblastine Plus Dipyridamole in Advanced Renal Cell Carcinoma A Hoosier Oncology Group Study
Adenocarcinoma of the Esophagus and Gastroesophageal Junction Clinical and Pathologic Assessment of Response to Induction Chemotherapy
Unusual Clinical Course of Chronic Myelogenous Leukemia A Case Report
Positron Emission Tomography Diagnosis Of Pulmonary Metastases In Osteogenic Sarcoma
Neoadjuvant Treatment of Stage IIIA Non-Small Cell Lung Cancer Long-Term Results
Phase II Trial of Amonafide in Patients with Advanced Metastatic or Recurrent Endometrial Adenocarcinoma A Southwest Oncology Group Study
Immunomodulation in the Treatment of Malignant Disorders
A Phase I Clinical Trial of a Combination of Mitoxantrone, 5-Fluorouracil, and High-Dose Leucovorin Given on a Day 1 and Day 8 Schedule to Patients with Metastatic Breast Cancer
In Vitro and In Vivo Cytogenetic Effects of Recombinant Interleukin-2 on Human Lymphocytes
Adjuvant Chemotherapy With Dacarbazine, Vindesine, and Cisplatin in Pathological Stage II Malignant Melanoma
Primary Radiation Therapy to T1 and T2 Breast Cancer Following Conservative Surgery Which Patients Should Be Boosted?
Neoadjuvant Cisplatin and Etoposide for Stage IIIA (Clinical N2) Non-Small Cell Lung Cancer
Treatment of Primary Fallopian Tube Carcinoma with Cisplatin-Containing Chemotherapy
High-Risk Early-Stage Ovarian Cancer Randomized Clinical Trial Comparing Cisplatin Plus Cyclophosphamide versus Whole Abdominal Radiotherapy
Bone Formation Markers and Pain Palliation in Bone Metastases Treated with Strontium-89
Recombinant Interferon Alpha-2b in the Treatment of Diffuse Malignant Pleural Mesothelioma
A Phase II Trial of Alternating Chemotherapy in Patients with Inoperable Non-Small Cell Lung Cancer
Breast Cancer : Reporting Results with Inflationary Arithmetic